Henry Schein, Inc. (HSIC)

Sector: Healthcare|Industry: Medical Distribution|Market Cap: $8.95B|Employees: 25K


Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

  1. Filings
  2. Company Profile

Business Summary

Henry Schein, Inc. is a solutions company for health care professionals, providing products and services primarily to office-based dental and medical practitioners, as well as alternate care sites. The company's philosophy is to help customers operate more efficiently and provide better clinical care. With over 91 years of experience, Henry Schein serves more than one million customers worldwide.

Key Statistics

  • Employees: Over 25,000
  • Geographic Footprint: Operations or affiliates in 33 countries and territories
  • Headquarters: Melville, New York
  • Founded: 91+ years of experience
  • Number of locations/facilities: 36 distribution centers and 22 manufacturing facilities

Leadership

  • CEO: Stanley M. Bergman (since 1989)
  • Vice Chairman & President: James P. Breslawski (since 2018)
  • Chief Executive Officer, North America Distribution Group: Brad Connett (since 2021)
  • Executive Vice President and Chief Operating Officer: Michael S. Ettinger (since 2022)
  • Senior Vice President, Chief Human Resources Officer: Lorelei McGlynn (since 2013)
  • Executive Vice President, Chief Strategic Officer: Mark E. Mlotek (since 2012)
  • Senior Vice President and Chief Legal Officer: Walter Siegel (since 2021)
  • Senior Vice President, Chief Financial Officer: Ronald N. South (since 2022)

Key Financial Metrics

  • Annual Revenue: $12.34 billion (FY2023)
  • Net Income Attributable to Henry Schein, Inc.: $416 million (FY2023)
  • Market Cap: Approximately $10.5 billion (as of July 1, 2023)
  • Total Assets: $10.57 billion (as of December 30, 2023)
  • Employees: Over 25,000
  • Key Financial Highlights: Sales and profitability generally higher in the third and fourth quarters due to seasonal products, purchasing patterns, and year-end promotions.

Products and Services

Henry Schein offers a broad range of products and services, including:

  • Consumable Supplies and Equipment: Distribution of branded and generic products, small equipment, laboratory products, large equipment, repair services, pharmaceuticals, vaccines, dental specialty products, diagnostic tests, infection-control products, and vitamins.
  • Technology and Value-Added Services: Software solutions for practice management, business analytics, patient engagement, and patient demand creation. Also includes electronic health records, patient communication services, practice consultancy, education, and financial service offerings.
  • Repair Services: Installation and repair services for dental handpieces, dental and medical small equipment, table-top sterilizers and large dental equipment.
  • Financial Services: Access to financial services and products provided by third-party suppliers, including non-recourse financing for equipment, technology and software products, practice financing, patient financing and credit card processing.

Key Business Segments

The company operates through two reportable segments:

  • Health Care Distribution: Distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, dental specialty products, diagnostic tests, infection-control products, PPE products and vitamins. This segment generated 93.5% of the company's consolidated net sales (FY2023).
  • Technology and Value-Added Services: Provides software, technology and other value-added services to health care practitioners, including practice management solutions, electronic health records, patient communication services, practice consultancy, education, integrated revenue cycle management and the facilitation of financial service offerings. This segment generated 6.5% of the company's consolidated net sales (FY2023).

Business Strategy

Henry Schein's mission is to provide innovative, integrated health care products and services, and to be trusted advisors and consultants to customers. The BOLD+1 Strategic Plan includes:

  • Building complementary software, specialty, and services businesses for high growth.
  • Operationalizing One Distribution to deliver exceptional customer experience, increased efficiency, and growth.
  • Leveraging One Schein to broaden and deepen relationships with customers.
  • Driving digital transformation for customers and for Henry Schein.
  • Creating value for stakeholders.

Industry Context

The global health care distribution industry is fragmented and diverse, ranging from sole practitioners to large group practices. The industry is experiencing growth due to factors like an aging population, increased health care awareness, and the proliferation of medical technology. Consolidation within the industry is expected to continue. Key competitors include:

  • Dental Market: Patterson Dental division of Patterson Companies, Inc. and Benco Dental Supply Company.
  • Medical Market: McKesson Corporation and Medline Industries, Inc.
  • Dental Software: Patterson Dental division of Patterson Companies, Inc., Carestream Health, Inc., Carestream Dental LLC, Centaur Software Development Co Pty Ltd., Open Dental Software, Inc., PlanetDDS LLC, Good Methods Global Inc. and Curve Dental, LLC.
  • Other Software: Vyne Therapeutics Inc., EDI-Health Group, Inc., Weave Communications, Inc., and Solutionreach, Inc.
  • Medical Practice Management and Electronic Medical Records: NextGen division of Quality Systems, Inc., eClinicalWorks, Allscripts Healthcare Solutions, Inc. and Epic Systems Corporation.

Risk Factors

  • Supply Chain Risks: Dependence on third-party manufacturers and suppliers, potential for supply interruptions, and forced labor allegations affecting the supply chain.
  • Technology and Innovation Risks: The ability to develop, acquire, and protect new products and technologies, particularly in the technology and value-added services segment.
  • Acquisition and Joint Venture Risks: Risks inherent in acquisitions, dispositions and joint ventures, including the failure to achieve anticipated benefits and integration challenges.
  • Cybersecurity Risks: Vulnerability to cybersecurity threats and data breaches, and the potential for disruptions to business operations and reputational harm.
  • Regulatory Risks: Compliance with extensive governmental regulations, including those related to pharmaceuticals, medical devices, data privacy and security, and health care fraud and abuse.

Last Updated

2024-02-28

(Generated from latest 10-K filing)